Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurology · Seronegative Autoimmune Brainstem Encephalitis

The Road to Diagnosis: Evaluating Mimics

At a Glance

A negative antibody test does not rule out autoimmune brainstem encephalitis. Doctors reach the diagnosis by combining symptoms, clinical progression, MRI and spinal-fluid results with testing for infections, demyelinating diseases, strokes, tumors, and other mimics.

Diagnosing seronegative autoimmune brainstem encephalitis is a careful process of assembling clinical clues. Because there is no single “positive” blood test to confirm the condition, doctors rely on a syndrome-based diagnosis [1]. This means they look at the whole picture—your symptoms, your test results, and your clinical progression—to conclude that an immune attack is the most likely cause [2][3].

This process requires the reasonable exclusion of alternatives, meaning your medical team must evaluate whether your symptoms are caused by more common issues like infections, strokes, or tumors before they can officially support an autoimmune diagnosis [2][4].

The Approach to Antibody Testing

To accurately call a condition “seronegative,” testing must be thorough. It is critical that your doctors test both your blood (serum) and your spinal fluid (CSF) [5][2]. Some targets are more sensitive in the spinal fluid, and paired testing at an experienced reference laboratory provides the clearest picture [5][6].

Specialized labs use two different types of tests to look for antibodies:

  • Cell-Based Assays (CBA): These tests use engineered cells to look for a specific, known “lock” that an antibody might “key” into. While very accurate, they can still produce false-negative or false-positive results [7][8].
  • Tissue-Based Assays (TBA): These tests apply your samples to thin slices of brain tissue to see if anything “sticks.” This can be a useful screening clue, but it is not proof of a pathogenic antibody or autoimmune disease on its own [7][4].

Evaluating the “Mimics”

Before confirming an autoimmune cause, your doctors must reasonably assess several conditions that look almost identical but require very different treatments [4][9]:

  • Infections: Viruses like VZV (the chickenpox/shingles virus) or Enterovirus, and bacteria like Listeria, can cause intense brainstem inflammation [10][11][12]. These are assessed using PCR (a test for genetic material) or cultures of your spinal fluid [13][14]. Importantly, because testing can sometimes be falsely negative, clinicians may need to start empiric antimicrobial treatment while results are pending.
  • Demyelinating Diseases: Conditions like Multiple Sclerosis (MS), MOGAD, and Neuromyelitis Optica (NMOSD) involve the immune system but primarily attack different targets, such as astrocytes or myelin [15][16]. These disorders can also produce brainstem-predominant lesions.
  • Bickerstaff Brainstem Encephalitis (BBE): This is a specific autoimmune condition that often follows an infection and is usually linked to a specific antibody called anti-GQ1b [17].
  • CLIPPERS: A rare inflammatory condition of the brainstem that often produces a suggestive “peppering” pattern of spots on an MRI [18][19]. Note that this pattern can also be mimicked by infection or lymphoma.
  • Cancers: Certain tumors, such as lymphoma or glioma, can mimic inflammation. In some cases, an immune attack is actually a “paraneoplastic” response, where the body creates antibodies to fight a hidden cancer, and those antibodies mistakenly attack the brainstem [20][21].

What to Look For in Your Records

When reviewing your records, look for these supportive pieces of the “diagnostic puzzle.” Test selection depends on your exposures, immune status, and imaging, so not every test is mandatory for every person.

Category What to Look For in Your Reports Why It Matters
CSF Basics Pleocytosis (high white cell count), High Protein [1] Supportive of active inflammation in the nervous system, though nonspecific.
Specialized CSF Oligoclonal Bands (OCB), IgG Index [22] Supportive of immune activation. Often seen in MS, but not specific.
Antibody Panels Serum & CSF paired testing [5] Helps substantiate a “seronegative” result when done at a specialty lab.
Infection Screen PCR for VZV, HSV; Listeria culture [11][13] Helps assess for infectious mimics, though negative results do not exclude every infection.
Mimic Panels MOG-IgG and AQP4-IgG [15] Helps differentiate from MOGAD and NMOSD.
Imaging MRI with Gadolinium (contrast) [3][18] Identifies suggestive patterns or rules out tumors and strokes.
Systemic Screen CT or PET scan of the body [20][23] Checks for hidden tumors that might be triggering the immune system (risk-stratified).

If your tests are negative but your symptoms and MRI strongly suggest an autoimmune attack, doctors may move forward with empiric treatment. While a positive response to steroids is supportive, it is not diagnostic proof of autoimmunity on its own, as lymphomas, CLIPPERS, and some infections can also transiently improve.

Common questions in this guide

What does seronegative mean in autoimmune brainstem encephalitis?
It means that testing did not find a recognized antibody associated with the condition. It does not automatically rule out an immune attack, because doctors also consider symptoms, progression, MRI findings, spinal-fluid results, and whether other causes have been reasonably excluded.
Why do doctors test both blood and spinal fluid?
Some antibody targets are easier to detect in spinal fluid than in blood, so paired testing can provide a clearer assessment. Testing may use cell-based and tissue-based assays, and results are best interpreted in the clinical context by an experienced laboratory and specialist.
What conditions can look like autoimmune brainstem encephalitis?
Infections such as VZV, enterovirus, and Listeria can cause similar brainstem inflammation. Multiple sclerosis, MOGAD, NMOSD, Bickerstaff brainstem encephalitis, CLIPPERS, strokes, lymphoma, and glioma may also resemble it and require different evaluation or treatment.
Can negative antibody or infection tests rule out the diagnosis?
No. Antibody assays can be falsely negative, and negative infection tests do not exclude every infection; if symptoms and MRI remain strongly suggestive, doctors may still consider autoimmune disease and sometimes start empiric treatment.
Does improving after steroids prove autoimmune encephalitis?
No. Improvement after steroids can support the possibility of inflammation, but infections, CLIPPERS, and lymphoma may also improve temporarily. Doctors use the entire clinical and testing picture rather than steroid response alone.
How do MRI findings affect the diagnosis of brainstem encephalitis?
MRI can show patterns that support inflammation and help identify strokes or tumors, but it is not a standalone confirmation. Doctors interpret normal or abnormal results alongside symptoms, clinical progression, spinal-fluid findings, antibody tests, and evaluation for mimics.
When might a CT or PET scan be recommended?
Depending on your clinical risk factors and other findings, doctors may use CT or PET imaging to look for a hidden cancer. This is important because some cancers can trigger a paraneoplastic immune response that affects the brainstem.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which clinical criteria did I meet to support a diagnosis of 'probable' autoimmune encephalitis despite my negative antibody tests?
  2. 2.Were my serum and CSF tested using both tissue-based (TBA) and cell-based (CBA) assays, and which laboratory performed these specialized tests?
  3. 3.Have we evaluated for common infectious mimics like Listeria, VZV, and Enterovirus through CSF PCR or culture testing?
  4. 4.How did you distinguish my symptoms from other demyelinating conditions like MOGAD or Neuromyelitis Optica (NMOSD)?
  5. 5.Given that my MRI results were [normal/abnormal], how does this affect our confidence in the diagnosis of brainstem encephalitis?
  6. 6.Based on my specific risk factors, is there a need for imaging (like a CT or PET scan) to check for an underlying cancer that could be driving this immune response?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    A clinical approach to diagnosis of autoimmune encephalitis.

    Graus F, Titulaer MJ, Balu R, et al.

    The Lancet. Neurology 2016; (15(4)):391-404.

    PMID: 26906964
  2. 2

    Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.

    Dalmau J, Graus F

    The Lancet. Neurology 2023; (22(6)):529-540 doi:10.1016/S1474-4422(23)00083-2.

    PMID: 37210100
  3. 3

    Autoimmune Encephalitis Criteria in Clinical Practice.

    Orozco E, Valencia-Sanchez C, Britton J, et al.

    Neurology. Clinical practice 2023; (13(3)):e200151 doi:10.1212/CPJ.0000000000200151.

    PMID: 37124463
  4. 4

    Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria.

    Van Steenhoven RW, de Vries JM, Bruijstens AL, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2023; (10(6)) doi:10.1212/NXI.0000000000200148.

    PMID: 37582614
  5. 5

    Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapy.

    Schwab H, Kegele J, Kowarik MC, et al.

    Frontiers in immunology 2026; (17()):1771609 doi:10.3389/fimmu.2026.1771609.

    PMID: 41884821
  6. 6

    Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis.

    Budhram A, Dubey D, Sechi E, et al.

    Clinical chemistry 2020; (66(12)):1496-1509 doi:10.1093/clinchem/hvaa254.

    PMID: 33221892
  7. 7

    Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis.

    Ricken G, Schwaiger C, De Simoni D, et al.

    Frontiers in neurology 2018; (9()):841 doi:10.3389/fneur.2018.00841.

    PMID: 30364136
  8. 8

    Neural Antibody Testing for Autoimmune Encephalitis: A Canadian Single-Centre Experience.

    Budhram A, Mirian A, McFadden S, et al.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2021; (48(6)):859-863 doi:10.1017/cjn.2021.23.

    PMID: 33557967
  9. 9

    Evaluation of multiple consensus criteria for autoimmune encephalitis and temporal analysis of symptoms in a pediatric encephalitis cohort.

    Pointon T, Ward R, Yeshokumar A, et al.

    Frontiers in neurology 2022; (13()):952317 doi:10.3389/fneur.2022.952317.

    PMID: 36237630
  10. 10

    Rhombencephalitis due to Listeria monocytogenes infection with GQ1b antibody positivity and multiple intracranial hemorrhage: a case report and literature review.

    Zhao Y, Xu C, Tuo H, et al.

    The Journal of international medical research 2021; (49(4)):300060521998568 doi:10.1177/0300060521998568.

    PMID: 33866842
  11. 11

    Slowly progressing varicella zoster brainstem encephalitis complicating Ramsay Hunt syndrome in an immunocompetent patient: case report and review of the literature.

    Ricigliano VAG, Saraceno L, Cavalli M, et al.

    Journal of neurovirology 2017; (23(6)):922-928 doi:10.1007/s13365-017-0575-3.

    PMID: 28905216
  12. 12

    Rhombencephalitis associated with varicella-zoster virus masquerading as Guillain-Barré syndrome.

    Al Shaaibi K, Phoophiboon V, Burns KEA

    BMC neurology 2025; (25(1)):324 doi:10.1186/s12883-025-04245-x.

    PMID: 40764927
  13. 13

    Listeria rhombencephalitis in the postpartum period.

    Schneider J, Kim JY, Oey M

    BMJ case reports 2025; (18(7)) doi:10.1136/bcr-2025-266790.

    PMID: 40659385
  14. 14

    Rhombencephalitis With Long Segment Transverse Myelitis: A Presentation With a Rare Etiology.

    Dubey P, Seth S, Rao P, Naphade P

    Cureus 2024; (16(9)):e69386 doi:10.7759/cureus.69386.

    PMID: 39411647
  15. 15

    Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.

    Mukherjee A, Roy D, Chakravarty A

    Current neurology and neuroscience reports 2025; (25(1)):45 doi:10.1007/s11910-025-01432-8.

    PMID: 40591029
  16. 16

    MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

    Jarius S, Kleiter I, Ruprecht K, et al.

    Journal of neuroinflammation 2016; (13(1)):281 doi:10.1186/s12974-016-0719-z.

    PMID: 27802825
  17. 17

    Case Report: Anti-GQ1b antibody-positive overlap syndrome: a pediatric case involving the brainstem, spinal cord, and peripheral nerves.

    Zhang SJ, Zhu W, Ying QL, et al.

    Frontiers in immunology 2026; (17()):1821721 doi:10.3389/fimmu.2026.1821721.

    PMID: 42625776
  18. 18

    Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

    Tobin WO, Guo Y, Krecke KN, et al.

    Brain : a journal of neurology 2017; (140(9)):2415-2425 doi:10.1093/brain/awx200.

    PMID: 29050399
  19. 19

    CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS.

    Taieb G, Mulero P, Psimaras D, et al.

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(9)):1027-1038 doi:10.1136/jnnp-2018-318957.

    PMID: 31072955
  20. 20

    Brain biopsy in patients with CLIPPERS syndrome: why and when.

    Galazky I, Büntjen L, Voges J, et al.

    Therapeutic advances in neurological disorders 2022; (15()):17562864211062821 doi:10.1177/17562864211062821.

    PMID: 35126669
  21. 21

    Clinical Reasoning: A 43-Year-Old Man With Subacute Onset of Vision Disturbances, Jaw Spasms, and Balance and Sleep Difficulties.

    Orozco E, Guo Y, Chen JJ, et al.

    Neurology 2022; (99(9)):387-392 doi:10.1212/WNL.0000000000200950.

    PMID: 35794020
  22. 22

    Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.

    Jarius S, Pellkofer H, Siebert N, et al.

    Journal of neuroinflammation 2020; (17(1)):261 doi:10.1186/s12974-020-01824-2.

    PMID: 32883348
  23. 23

    Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies.

    Al-Chalabi M, DelCimmuto NR, Beran A, et al.

    Multiple sclerosis and related disorders 2022; (68()):104112 doi:10.1016/j.msard.2022.104112.

    PMID: 36029706

This page explains how clinicians evaluate antibody-negative autoimmune brainstem encephalitis and its mimics for educational purposes only; it does not replace medical advice. Your neurologist and care team must interpret your tests and decide on treatment.

Get notified when new evidence is published on Non-specific autoimmune brainstem encephalitis without characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.